MLL-AF9 is a fusion gene resulting from the chromosomal translocation t(9;11)(p22;q23) and has the potent leukemogenic potential to transform hematopoietic progenitor cells into AML cells10,11. Here, KMT2A is linked to acute myeloid leukemia.